Emcure Pharma launches campaign for women's health, well-being

Published On 2021-04-11 03:30 GMT   |   Update On 2021-04-11 03:30 GMT

Pune: Emcure Pharmaceuticals Ltd. has recently announced the launch of 'Uncondition Yourself' - an initiative dedicated towards women's well-being. The campaign launched on the occasion of 'World Health Day' will seek to identify and address the prevalent notions and misconceptions about women's health and well-being from the cultural and social context in India.

In the first phase, the campaign aims to put forth the challenges and connect with relevant influencers to initiate a step towards building a supportive ecosystem for women in the workforce. The campaign will involve on-ground engagement and online activities at a national level.

Speaking on the occasion, Ms. Namita Thapar, Executive Director, Emcure Pharmaceuticals, said, "Despite the economic advances we have made, even today, issues related to women's health are associated with irrational taboos. These lead to stigmatization and more worryingly holding back among women about their health issues. Through the 'Uncondition Yourself' initiative, we hope to bring to light important health issues India's significant women workforce face, and to educate them to make informed choices in their day-to-day actions."
The campaign is an outcome of an online talk show 'Uncondition yourself with Namita' featuring candid heart to heart conversations on women's health issues, giving accurate information and dispelling various myths. This programme received a tremendous response which encouraged the company to launch its 'Uncondition Yourself' initiative to engage with a wider audience.

Read also: Emcure Secures CDSCO Committee nod for manufacturing, marketing of Metoprolol Telmisartan FDC

Emcure develops and sells a wide range of branded and generic formulations, API and biotechnology products in over 70 markets including India, Europe, Canada, Russia and nations across Latin America and the Middle-East through a strong global network of 19 subsidiaries.

The company's diversified portfolio of offerings caters to pain & analgesics, vitamins, minerals and nutrients, anti-infectives, diabetes, and neuroscience segments.

Read also: Johnson and Johnson to start Indian trial of single-shot COVID vaccine: Report





Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News